Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
745.25
Change Change %
-17.45 -2.29%

Updated:24 Sep, 2018, 12:59 PM IST

BSE
745.00
Change Change %
-16.65 -2.19%

Updated:24 Sep, 2018, 12:59 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Nirmal Bang
N/A
07-04-2016 Buy 762.15 894.00
N/A
Target Hit Long (1Y)
07-04-2017

Nirmal Bang initiates Aurobindo Pharma with buy

Aurobindo Pharma has transformed itself from an API player to an established formulations player in the generic space. There are multiple growth levers in place now with the change in business mix. A strong new drug application pipeline to drive US sales. Value stock at 18 times its FY2018 estimated earnings per share of Rs 49.7.

Top